Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Atazanavir 300mg / Cobicistat 150mg tablets
0503010ALAAAAAA
|
Atazanavir/cobicistat | Atazanavir and cobicistat | Infections | No data available |
|
Atazanavir 300mg capsules
0503010L0AAADAD
|
Atazanavir | Atazanavir | Infections | No data available |
|
Augmentin 375mg dispersible tablets
0501013K0BBABAB
|
Augmentin | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
|
Avelox 400mg/250ml solution for infusion bottles
0501120Y0BBABAB
|
Avelox | Moxifloxacin | Infections | No data available |
|
Avelox I.V. 400mg/250ml infusion bags
0501120Y0BBACAC
|
Avelox | Moxifloxacin | Infections | No data available |
|
Azactam 1g powder for solution for injection vials
0501023A0BBABAB
|
Azactam | Aztreonam | Infections | No data available |
|
Azactam 2g powder for solution for injection vials
0501023A0BBAAAA
|
Azactam | Aztreonam | Infections | No data available |
|
Azactam 500mg powder for solution for injection vials
0501023A0BBACAC
|
Azactam | Aztreonam | Infections | No data available |
|
Azocan-P 150mg capsules
0502010B0BFADAB
|
Azocan | Fluconazole | Infections | No data available |
|
Aztreonam 1g powder for solution for injection vials
0501023A0AAABAB
|
Aztreonam | Aztreonam | Infections | No data available |
|
Aztreonam 2g powder for solution for injection vials
0501023A0AAAAAA
|
Aztreonam | Aztreonam | Infections | No data available |
|
Aztreonam 500mg powder for solution for injection vials
0501023A0AAACAC
|
Aztreonam | Aztreonam | Infections | No data available |
|
Bacticlor MR 375mg tablets
0501021A0BEAAAG
|
Bacticlor | Cefaclor | Infections | No data available |
|
Baloxavir marboxil 40mg tablets
0503040D0AAAAAA
|
Baloxavir marboxil | Baloxavir marboxil | Infections | No data available |
|
Baloxavir marboxil 80mg tablets
0503040D0AAABAB
|
Baloxavir marboxil | Baloxavir marboxil | Infections | No data available |
|
Baxan 125mg/5ml oral suspension
0501021B0BBABAB
|
Baxan | Cefadroxil | Infections | No data available |
|
Baxan 250mg/5ml oral suspension
0501021B0BBACAC
|
Baxan | Cefadroxil | Infections | No data available |
|
Baxan 500mg capsules
0501021B0BBAAAA
|
Baxan | Cefadroxil | Infections | No data available |
|
Baxan 500mg/5ml oral suspension
0501021B0BBADAD
|
Baxan | Cefadroxil | Infections | No data available |
|
Bedaquiline 100mg tablets
0501090V0AAAAAA
|
Bedaquiline | Bedaquiline | Infections | No data available |
|
Bell's Thrush Relief Oral 150mg capsules
0502010B0BGAAAB
|
Bell's (Fluconazole) | Fluconazole | Infections | No data available |
|
Benznidazole 50mg tablets
0504060B0AAAAAA
|
Benznidazole | Benznidazole | Infections | No data available |
|
Beyfortus 100mg/1ml inj pre-filled syringes
0503050C0BBAAAA
|
Beyfortus | Nirsevimab | Infections | No data available |
|
Beyfortus 50mg/0.5ml inj pre-filled syringes
0503050C0BBABAB
|
Beyfortus | Nirsevimab | Infections | No data available |
|
Bictegravir 30mg /Emtr 120mg /Tenofovir alafenamide 15mg tab
0503010AQAAABAB
|
Bictegravir/emtricitabine/tenofovir alafenamide | Bictegravir/emtricitabine/tenofovir alafenamide | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.